Patent Assignment
Reel/Frame 024614/0792
Change of Name
Recorded: 2010-06-30
Pages: 2
Assignor
ARGENTA ORAL THERAPEUTICS LIMITED
Executed: 2010-02-26
Assignee
PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
STOKE COURT, STOKE POGES, SLOUGH SL2 4SY, UNITED KINGDOM
Covered Properties
(2)
Quinoline Derivatives as CRTH2 Receptor Ligands
Application:
12/531,367 →
Publication:
US 2010/0144786
Quinolines and Their Therapeutic Use
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 17, 2010
From: CRAMP, MICHAEL COLIN; ARIENZO, ROSA; HYND, GEORGE; CRACKETT, PETER
To: ARGENTA ORAL THERAPEUTICS LIMITED
Reel/Frame 023947/0001 →
Assignment of Assignor's Interest
Feb 18, 2010
From: MONTANA, JOHN GARY; FINCH, HARRY; HYND, GEORGE; CRAMP, MICHAEL COLIN
To: ARGENTA ORAL THERAPEUTICS LIMITED
Reel/Frame 023955/0426 →
Assignment of Assignor's Interest
Apr 23, 2019
From: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
To: GB001, INC.
Reel/Frame 048974/0193 →
Security Interest
May 3, 2019
From: GOSSAMER BIO, INC.; GOSSAMER BIO SERVICES, INC.; GB001, INC.; GB002, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 049081/0335 →
Release of Security Interest in Intellectual Property Collateral at Reel/Frame No. 49081/0335
May 3, 2024
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: GOSSAMER BIO, INC.; GOSSAMER BIO SERVICES, INC.; GB001, INC.; GB002, INC.
Reel/Frame 067310/0307 →